Mastocytosis: the safety of different COVID-19 vaccines
Arq. Asma, Alerg. Imunol; 6 (4), 2022
The COVID-19 pandemic has forced the development of vaccines to fight SARS-CoV-2. After vaccination began, reports of adverse reactions, including anaphylaxis, emerged. This raised concerns about the safety of COVID-19 vaccines in patients diagnosed with mastocytosis. The authors share their experience i...